Wine Is Good For You (Again... For Now)
Filed in archive Wine News on October 30, 2007
`

I'm sure that tomorrow there will be a headline warning us that wine increases the risk of some such disease, because that's the way things seem to go (and not just with wine, with anything - eggs, chocolate, coffee... pretty much everything I enjoy). But for now, I get to write about the positive health benefits of wine again, thanks to the polyphenols it contains. Of course, that's only partially true because you'd need to drink far more wine per day than is recommended in order to get the health benefits.
From Science Daily:
According to the authors, the amount of polyphenols necessary to obtain an anti-cancer effect is the equivalent of drinking about a bottle of red wine each day. This amount of daily alcohol consumption obviously is unhealthy, but the research suggests that polyphenols extracted from plants or red wine could be converted into a pill that is highly likely to be safe. Such a pill also would be relatively easy and inexpensive to create and deliver.Nevertheless, it's interesting and I think shows that wine can be a beneficial part of one's diet. I have to imagine that every little bit helps.
Permalink: Wine Is Good For You (Again... For Now)
Tags: redwine polyphenols cancer heartdisease wine good+again wine+good linked+breast
Vote for Wine Is Good For You (Again... For Now):
|
Rating: 9.00 out of 3 vote(s) cast.
|
Response from:
Mark Juliano
(11/01/07 2:59pm)
Most Popular
American Wines
Australian Wines
Best of
California Wines
Canadian Wines
Celebrities and Wine
Champagne
Cheap Wines
Did you know
Drinking
Food and Wine
French Wines
German Wines
Greek Wines
Holiday Wine
information about
Italian Wines
Japanese Wines
Misc
New York Wines

Harvard Medical School and Xenomis have signed a technology licensing agreement for the development of nutraceutical products based upon proprietary stressed plant science (xenohormesis), with far reaching physiological benefits. Xenomis’ product containing a unique combination of Resveratrol and other polyphenols are expected to be introduced within one (1) year, and Xenomis is looking to partnering with Tier One industry player for marketing and distribution.
Isaac Kohlberg, of Harvard Medical School's Technology Development office has said that Xenomis can potentially advance this research into practical development and application much faster and more efficiently than would otherwise be possible.
Xenomis uses a proprietary Australian Extraction process to concentrate a range of xenohormetic molecules (Xeno Factors) including Resveratrol, Quercetin and other polyphenols from red wine grapes. The company has already conducted a human clinical trial with its products, and looks forward to further laboratory analyses and clinical trials.
Numerous studies of Xeno Factors suggest major health benefits, including, longevity, endurance and enhanced memory, and Resveratrol has been linked to a range of human benefits. The Xenomis website address is http://www.xenomis.com.